Join
Live feed
·
PRReleasevia Quantisnow
BioRestorative Therapies Inc. logo

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

ByQuantisnow·Wall Street's wire, on your screen.
BRTX· BioRestorative Therapies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BRTX (BioRestorative Therapies Inc.) and more on Quantisnow.